GemPharmatech, a recognized global frontrunner in preclinical research services and genetically-engineered mouse models, has announced a groundbreaking partnership with Memorial...

In recent years, the landscape of treatment for adult acute lymphoblastic leukemia (ALL) has undergone a profound transformation, shifting away...

In the ever-evolving landscape of cancer treatment, researchers are consistently pursuing innovative strategies to combat this multifaceted disease. One of...

In a groundbreaking advancement that could redefine the therapeutic landscape for lung cancer, researchers have unveiled a meticulously engineered nanostructured...

In a groundbreaking study published in BMC Cancer, researchers have unveiled a novel gene model linked to angiogenesis that significantly...

In the challenging landscape of oncology, glioblastoma multiforme (GBM) represents one of the most formidable adversaries. This highly aggressive form...

In a groundbreaking advancement that could reshape the future of hepatocellular carcinoma (HCC) treatment, scientists have developed an innovative deep...

In a groundbreaking study published in BMC Cancer, researchers have unveiled the potent anticancer properties of cephalomannine, a compound showing...

In a groundbreaking study published in BMC Cancer, researchers have developed a highly predictive nomogram model designed to assess the...

A groundbreaking phase II clinical trial has unveiled promising results in the fight against advanced hepatocellular carcinoma (HCC) by combining...